Day: October 17, 2023

  UV1, in combination with the checkpoint inhibitors ipilimumab and nivolumab from Bristol-Myers Squibb, demonstrated a clinically meaningful overall survival benefit with no added toxicities, compared to ipilimumab and nivolumab alone, in the second-line treatment of patients with malignant mesothelioma The UV1 cancer vaccination combined with ipilimumab and nivolumab reduced the risk of death by 27%, meeting the protocol predefined threshold for statistical significance, in a hard-to-treat patient group with currently no standard-of-care treatment options First demonstration of universal cancer vaccine efficacy and therapeutic impact in a randomized Phase II clinical trial, supporting further clinical development NIPU results to be presented by the Principal Investigator Professor Åslaug Helland, MD, Ph.D., at the ESMO Congress 2023...

WithSecure Corporation, Stock Exchange Release (Inside information), 17 October 2023, 17:30 EET WithSecure Corporation, Inside information: Consulting goodwill impairment of EUR 6.2 million As part of the preparation of its third quarter interim report, WithSecure has tested the values of the intangible assets and goodwill. As a result of this testing, an impairment of EUR 6.2 million of the goodwill related to consulting business will be recognized as part of the third quarter interim report result. The impairment will not have an impact on WithSecure cashflow or Adjusted EBITDA. Consulting goodwill is resulting from the acquisition of nSense (Denmark) in 2015, Inverse Path (Italy) in 2017, Digital Assurance (UK) in 2017, and MWR Infosecurity (UK) in 2018. In 2023, WithSecure lowered the revenue outlook of its consulting business, due...

ATLANTA, Oct. 17, 2023 (GLOBE NEWSWIRE) —  Gray Television, Inc. (“Gray”) (NYSE: GTN) has released a new investor presentation providing Gray’s perspective on the broadcast industry and the company in the current network and retransmission landscape. The presentation outlines Gray’s belief that the Broadcast Industry and Gray are positioned well for continued growth in retransmission revenues in light of the continuing market trends and recent industry developments. The presentation is available on Gray’s website at https://gray.tv/investorrelations#presentations. Forward-Looking Statements: This press release and the presentation contains certain forward-looking statements that are based largely on Gray’s current expectations and reflect various estimates and assumptions by Gray. These statements may be identified by words such...

MARLBOROUGH, Mass., Oct. 17, 2023 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that researchers from Akoya Biosciences and The University of Queensland’s Frazer Institute have comprehensively mapped the spatial proteome of head and neck squamous cell carcinoma (HNSCC) using ultrahigh-plex spatial phenotyping. Spatial phenotyping consists of whole-slide imaging of tissue sections at single-cell resolution to visualize and quantitate biomarker expression and reveal how cells interact and organize across the entire tissue landscape. The study, published in GEN Biotechnology in an article titled “Mapping the Spatial Proteome of Head and Neck Tumors: Key Immune Mediators and Metabolic Determinants in the Tumor Microenvironment” identified a high degree of intra- and...